Preclinical Evaluation of (99m)Tc-Labeled GRPR Antagonists maSSS/SES-PEG(2)-RM26 for Imaging of Prostate Cancer

Background: Gastrin-releasing peptide receptor (GRPR) is an important target for imaging of prostate cancer. The wide availability of single-photon emission computed tomography/computed tomography (SPECT/CT) and the generator-produced (99m)Tc can be utilized to facilitate the use of GRPR-targeting r...

Descripción completa

Detalles Bibliográficos
Autores principales: Abouzayed, Ayman, Rinne, Sara S., Sabahnoo, Hamideh, Sörensen, Jens, Chernov, Vladimir, Tolmachev, Vladimir, Orlova, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912279/
https://www.ncbi.nlm.nih.gov/pubmed/33573232
http://dx.doi.org/10.3390/pharmaceutics13020182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912279/
https://www.ncbi.nlm.nih.gov/pubmed/33573232
http://dx.doi.org/10.3390/pharmaceutics13020182

Ejemplares similares